Results 181 to 190 of about 337,805 (310)

Vitamin D therapy in diabetic kidney disease.

, 2014
Mahmoud Rafieian‐Kopaei, Hamid Nasri
openalex   +1 more source

Supplementary Material for: Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial

, 2019
George L. Bakris, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luís M. Ruilope, Christina Nowack, Peter Kolkhof, Ana Carina Ferreira, Patrick Schloemer, Jingmei Li, On Behalf Of The FIDELIO-DKD Study Investigators   +10 more
openalex   +1 more source

Fluorinated Carnitine Derivatives as Tools to Visualise Carnitine Transport and Metabolism

Advanced Science, EarlyView.
Fluorinated carnitines, fluoromethyl carnitine (FMC) and [18F]fluoromethyl carnitine ([18F]FMC), are synthesised and established as powerful probes to interrogate carnitine biology. The multimodal detection facilitated by fluorine labelling, including 19F NMR, mass spectrometry, and positron emission tomography imaging, allowed for visualisation of ...
Richard S. Edwards, Ella‐May Hards, Sofia N. dos Santos, Hannah E. Greenwood, Madeleine E. George, Andrea Emanuelli, Muhammet Tanc, Thomas R. Eykyn, Timothy H. Witney   +8 more
wiley   +1 more source

Study on Predictive Models for Differential Diagnosis of Diabetic Kidney Disease and Non-Diabetic Kidney Disease Based on Clinical and Biochemical Indicators. [PDF]

Int J Med Sci
Feng P, Deng X, Gan W, Song Y, Yang Y, Zhang R, Li J, Lin W.   +7 more
europepmc   +1 more source

Triple therapy of RAS inhibitors, dapagliflozin, and finerenone in diabetic kidney disease patients with nephrotic-range proteinuria: a real-world study [PDF]

Chenjie Gu, Xinwei Li, Xianan Guo, Jingying Zhou, Kang Le, Ming Fang   +5 more
openalex   +1 more source

A Novel 10‐Protein Score for Liver Fat Content Predicts Cardiovascular‐Kidney‐Metabolic Disease Risk

Advanced Science, EarlyView.
A novel 10‐protein plasma score precisely quantifies liver fat, outperforming the fatty liver index. It robustly predicts the risk of numerous cardiovascular‐kidney‐metabolic diseases and integrates with genetic data for precision prevention, offering a practical alternative to magnetic resonance imaging (MRI). Abstract Liver fat content (LFC) is a key
Xiaoqin Gan, Yuanxiu Wei, Yiting Wu, Xinyue Su, Gangling Wang, Sisi Yang, Ziliang Ye, Yanjun Zhang, Hao Xiang, Yu Huang, Yiwei Zhang, Yuanyuan Zhang, Xianhui Qin   +12 more
wiley   +1 more source

Soluble guanylate cyclase modulators-a novel therapeutic approach for diabetic kidney disease. [PDF]

Ren Fail
Xu Y, Wu X, Ge M, Liang K, Xing J, Zhang P, Li H, Guo Z, Mei X.   +8 more
europepmc   +1 more source

Chronic Kidney Disease and Diabetic Retinopathy in Patients with Type 2 Diabetes

, 2016
Antonio Rodríguez‐Poncelas, Xavier Mundet, Sònia Miravet-Jiménez, Aina Casellas, Joan Barrot, Josep Franch‐Nadal, Gabriel Coll de Tuero   +6 more
openalex   +2 more sources

Pancreatic transplantation using duct occlusion technique [PDF]

, 1988
Abendroth, D., Illner, Wolf-Dieter, Land, Walter, Landgraf, R.   +3 more
core   +1 more source

Nanozyme‐Integrated Hydrogel Targeting AGEs for Diabetic Osteoarthritis Therapy

Advanced Science, EarlyView.
A nanozyme–integrated hydrogel (PTC‐MP) exhibiting with mild photothermal effects is constructed, and a “3R” (restrain‐restore‐reinforce) strategy is proposed for diabetic osteoarthritis (DOA) treatment based on advanced glycation end products (AGEs) targeting.
Rui Chen, Yanguo Su, Guiyuan Zhao, Jiaojiao Tao, Qijie Diao, Guangli Xiang, Tianze Jiang, Lu Han, Xia Zhao   +8 more
wiley   +1 more source